Cargando…
Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice
BACKGROUND: We reported that roflumilast, a phosphodiesterase 4 inhibitor, given orally at 5 mg/kg to mice prevented the development of emphysema in a chronic model of cigarette smoke exposure, while at 1 mg/kg was ineffective. Here we investigated the effects of roflumilast on the volume density (V...
Autores principales: | Martorana, Piero A, Lunghi, Benedetta, Lucattelli, Monica, De Cunto, Giovanna, Beume, Rolf, Lungarella, Giuseppe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533284/ https://www.ncbi.nlm.nih.gov/pubmed/18755021 http://dx.doi.org/10.1186/1471-2466-8-17 |
Ejemplares similares
-
Smoking p66Shc Knocked Out Mice Develop Respiratory Bronchiolitis with Fibrosis but Not Emphysema
por: Lunghi, Benedetta, et al.
Publicado: (2015) -
Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models
por: Lucattelli, Monica, et al.
Publicado: (2005) -
Innate Immunity and Cell Surface Receptors in the Pathogenesis of COPD: Insights from Mouse Smoking Models
por: De Cunto, Giovanna, et al.
Publicado: (2020) -
Smoking Cessation in Mice Does Not Switch off Persistent Lung Inflammation and Does Not Restore the Expression of HDAC2 and SIRT1
por: De Cunto, Giovanna, et al.
Publicado: (2022) -
Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice
por: Raju, S. Vamsee, et al.
Publicado: (2017)